Dr Reddy Labs launches 2-DG oral anti-COVID drug commercially, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

In the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand coverage to the rest of India., In the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand coverage to the rest of India., , Read More

Leave a Reply

Your email address will not be published. Required fields are marked *